Medication info
Teddy Metr Extended Release Tablet 10/750 mg

Teddy Metr Extended Release Tablet 10/750 mg

Prescription medicationTabletOral
Ingredient · strength
Teneligliptin Hydrochloride Hydrate›13mg / 1 tabletMetformin Hydrochloride›750mg / 1 tablet
Manufacturer / importer
Dongwha Pharmaceutical Co., Ltd.
Appearance
Yellow oval-shaped extended-release film-coated tablet
Packaging
30 tablets/bottle
Approval status
Active

MFDS item code 202201437 · Approved 2022.04.04 · Insurance code 642707250

Summary

Main use
Improvement of glycemic control in patients with type 2 diabetes mellitus
Who takes it
Adults
Adult dose
The dose of this medicine should be determined based on each patient's current treatment regimen, efficacy, and tolerability. This medicine is generally administered once daily with the evening meal, and the dose should be titrated gradually to reduce gastrointestinal adverse reactions associated with metformin. Take one 20/1000mg extended-release tablet once daily. Patients taking the 10/750mg or 10/500mg extended-release tablets should take 2 tablets together once daily. For patients who do not achieve adequate glycemic control with metformin monotherapy, the initial dose of this medicine should provide teneligliptin 20 mg once daily and the patient's current dose of metformin. For patients switching from combination therapy with teneligliptin and metformin to this medicine, the dose of this medicine may be started at the patient's current doses of teneligliptin and metformin. When switching from immediate-release metformin to an extended-release formulation, glycemic control should be closely monitored and the dose adjusted as appropriate. When coadministered with a sulfonylurea, a reduction in the sulfonylurea dose may be considered to reduce the risk of hypoglycemia. The maximum recommended daily dose is teneligliptin 20mg and extended-release metformin 2000mg. The safety and efficacy of this medicine have not been specifically evaluated in patients switching to it from other glucose-lowering agents. Because this may cause changes in glycemic control, any change in the treatment of patients with type 2 diabetes should be made under careful monitoring. To maintain its extended-release properties, swallow this medicine whole; do not split, crush, grind, or chew it.

Ingredients

Manufacturer
Dongwha Pharmaceutical Co., Ltd.

Efficacy & effects

Improvement of glycemic control in patients with type 2 diabetes mellitus

View approved original text

This medication is used to aid in the improvement of blood sugar control in patients with type 2 diabetes alongside dietary and exercise therapies. Teneligliptin and metformin act together to effectively lower blood sugar levels. Therefore, it can help those who struggle with blood sugar management. Regular use of this medication can enhance blood sugar control, assisting individuals in maintaining a healthy lifestyle. Positive effects on the patient's blood sugar management can be expected.

How to take

Adult dose

The dose of this medicine should be determined based on each patient's current treatment regimen, efficacy, and tolerability. This medicine is generally administered once daily with the evening meal, and the dose should be titrated gradually to reduce gastrointestinal adverse reactions associated with metformin. Take one 20/1000mg extended-release tablet once daily. Patients taking the 10/750mg or 10/500mg extended-release tablets should take 2 tablets together once daily. For patients who do not achieve adequate glycemic control with metformin monotherapy, the initial dose of this medicine should provide teneligliptin 20 mg once daily and the patient's current dose of metformin. For patients switching from combination therapy with teneligliptin and metformin to this medicine, the dose of this medicine may be started at the patient's current doses of teneligliptin and metformin. When switching from immediate-release metformin to an extended-release formulation, glycemic control should be closely monitored and the dose adjusted as appropriate. When coadministered with a sulfonylurea, a reduction in the sulfonylurea dose may be considered to reduce the risk of hypoglycemia. The maximum recommended daily dose is teneligliptin 20mg and extended-release metformin 2000mg. The safety and efficacy of this medicine have not been specifically evaluated in patients switching to it from other glucose-lowering agents. Because this may cause changes in glycemic control, any change in the treatment of patients with type 2 diabetes should be made under careful monitoring. To maintain its extended-release properties, swallow this medicine whole; do not split, crush, grind, or chew it.

Precautions

This medication is used for the treatment of diabetes and has the effect of lowering blood sugar levels. However, serious side effects such as lactic acidosis may rarely occur, so caution is advised. It should not be administered to patients with severely reduced kidney function, heart failure, or liver dysfunction. Patients who are scheduled to undergo testing with iodine-based contrast agents should discontinue use of this medication 48 hours prior to the test and should resume taking it only after kidney function is confirmed to be normal post-test. Women who are pregnant or may become pregnant are advised to avoid using this medication. During the use of this medication, hypoglycemic symptoms may occur, so patients, especially those taking insulin or other diabetes medications, should be aware of low blood sugar. If symptoms of acute pancreatitis occur, consult a doctor immediately, and if symptoms like abdominal pain or vomiting persist, discontinue use. Additionally, this medication should be used with caution in patients with allergies to certain coloring ingredients. Elderly patients often have decreased kidney function, so regular kidney function tests should be conducted, and appropriate dosage adjustments must be made. In cases of overdose, seek medical attention immediately, as blood dialysis may be necessary. It is advisable to avoid alcohol consumption while on this medication, and in situations of dehydration, severe infection, or surgery, temporarily stopping the medication may be necessary. Regular blood tests are recommended, as vitamin B12 levels may decrease during the use of this medication. Patients who drive or perform high-risk jobs should be particularly cautious about symptoms of hypoglycemia or lactic acidosis. As this medication may interact with other medications, patients should inform their doctor or pharmacist of any other medications they are taking. It is advisable for breastfeeding women to avoid this medication and consult healthcare providers regarding its use.

Side effects

Severe lactic acidosis, severe hypoglycemia, hypoglycemia, constipation, intestinal obstruction, liver function disorder, interstitial pneumonia, similar pemphigus, acute pancreatitis, dizziness, abdominal distension, abdominal discomfort, nausea, abdominal pain, bloating, stomatitis, gastric polyp, colonic polyp, duodenal ulcer, gastroesophageal reflux disease, diarrhea, decreased appetite, increased amylase, increased lipase, elevated AST (GOT), elevated ALT (GPT), elevated GGT, elevated ALP, proteinuria, ketonuria, potential hematuria, eczema, rash, itching, allergic dermatitis, arthralgia, elevated CK (CPK), increased serum potassium levels, fatigue, allergic rhinitis, elevated serum uric acid, peripheral edema, herpes zoster, limb pain, upper abdominal pain, gastritis, upper respiratory infection, tremor, headache, asthenia, hunger, fatigue, facial edema, dyspepsia, nausea, viral upper respiratory infection, rhinitis, cold sweat, diabetic retinopathy, vision decline, cough, pulmonary congestion, shortness of breath, drug overdose, benign prostatic hyperplasia, headache, diarrhea, chronic gastritis, irritable bowel syndrome, fatigue, cerebral infarction, hyperglycemia, liver biopsy, neutropenia, abnormal blood glucose, increased blood glucose, increased blood pressure, hepatic coma, lumbar spinal canal stenosis, disc herniation in the spine, disc disorders in the spine, spinal ligament ossification, foraminal stenosis in the spine, rotator cuff syndrome, bladder mass, ureterolithiasis, urinary stones, coronary artery disease, unstable angina, gastroesophageal reflux disease, gastric polyp, gastritis, bile duct obstruction, chronic cholecystitis, soft tissue infection, pneumonia, cataract, depression, iliac artery stenosis, vertigo, benign prostatic hyperplasia, knee surgery, vomiting, abdominal pain, gastrointestinal motility disorder, decreased gastrointestinal motility, enteritis, toothache, anal-rectal discomfort, acquired mixed hyperlipidemia, hypertriglyceridemia, vitamin D deficiency, abnormal weight gain, essential hypertension, orthostatic hypotension, white coat hypertension, bleeding, increased blood glucose, abnormal sputum, toxic hepatitis, non-alcoholic fatty liver disease, alcoholic liver disease, eyelid injury, ligament sprain, lip injury, contusion, urticaria, glaucoma, blurred vision, age-related macular degeneration, hyperthyroidism, hyperparathyroidism, angina pectoris, otalgia, iron deficiency anemia, food allergy, pressure ulcer, hearing loss, endolymphatic hydrops, insomnia, ovarian cyst, vulvar pruritus, menopausal symptoms, uterine purulent disease, gastroenteritis, influenza, subcutaneous abscess, musculoskeletal chest pain, disc degeneration in the spine, falls, animal bites, distal radius fracture, chronic bronchitis, nasal turbinate hypertrophy, atherosclerosis, atrial fibrillation, hypothyroidism, anxiety disorder due to general medical conditions

Not everyone experiences these, and they can vary from person to person.

Storage

This medication should be stored in a tightly closed container to prevent air exposure and kept at room temperature between 1 and 30 degrees Celsius. This will help maintain the medication's effectiveness and prevent degradation.

Appearance and packaging

Appearance

Yellow oval-shaped extended-release film-coated tablet

Package unit

30 tablets/bottle

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.